The incidence of Treacher Collins syndrome is about 1:50,000 live births; about 40% of cases have a previous family history, while the remaining 60% represent de novo mutations of the TCOF1 gene [7].
Characteristic features of the disease include mandibular and malar hypoplasia with or without cleft zygoma; multiple abnormalities of the ears (microtia; dysplastic ears often associated with atresia of the external auditory canals and anomalies of the middle ear ossicles leading to conductive hearing loss); downslanting (“antimongoloid”) palpebral fissures with colobomas of the lower eyelids and partial or total absence of the lower eyelashes; macrostomia; cleft palate; choanal atresia or stenosis; and vision loss [8,9].
Additional findings are more rarely described in the literature, including encephalocele, ocular malformations, and extracraniofacial anomalies involving thyroid, thymus, heart, splenules, ectopic adrenal gland tissue, and hypoplastic external genitalia [10].
The spectrum of phenotypic findings in Treacher Collins syndrome varies from mild forms, clinically almost undetectable, to severe cases resulting in perinatal death or requiring emergent tracheostomy due to breathing problems from micrognathia and lingual obstruction of the hypopharynx [2].
Developmental delays were reported in only 5% of cases [9], usually as sequelae of hearing loss; thus early diagnosis and treatment can prevent associated developmental and educational disability.
Ultrasonographic examination plays a crucial role especially in detection of de novo Treacher Collins cases, and is very important in assessment of the severity of the findings in both de novo cases and cases with a positive family history. 3D ultrasonography adds information to the assessment of facial dysmorphism and more clearly illustrates some of the more subtle findings, such as downslanting palpebral fissures or macrostomia. The combination of retrognathia, microtia (with dysplastic, malformed pinnae), downslanting palpebral fissures, and macrostomia were the most significant findings in our case, leading to the suspicion of Treacher Collins syndrome at 19 weeks, 1 day of pregnancy, observed using both 2D and 3D imaging. Retrospective views of the first-trimester images also revealed micrognathia/retrognathia of the fetus, but unfortunately we did not note this important finding at that time.
The differential diagnosis includes other phenotypically similar entities, especially:
-
Retinoid acid embryopathy (in addition to microtia, cardiovascular and central nervous system anomalies are present) [11];
-
Nager syndrome (here, there are also preaxial limb abnormalities and the mandible is considerably more hypoplastic) [2,12];
-
Miller syndrome (a cleft lip is more frequently seen; postaxial limb anomalies are present, such as incomplete development of the fifth digital ray of all limbs; also, occasionally, heart defects are present) [2, 13];
- Goldenhar syndrome (usually featuring unilateral facial abnormalities – microtia; malar, maxillary or mandibular hypoplasia; hemi- or hypoplastic vertebrae, most commonly of the cervical region) [14];
- Pierre Robin syndrome (micrognathia, but with normal ears) [15]; and other anomalies, usually distinguishable by extrafacial features.
The sonographic findings - our suspicion of Treacher Collins syndrome - were crucially important for the geneticist, who added gene sequencing to the usual amniocentesis panel, confirming the diagnosis. Without this additional genetic assessment, the result of a classic amniocentesis would have been “normal”.
This underscores the importance of an extremely meticulous prenatal ultrasound examination using grayscale as well as 3D/4D imaging. 3D/4D imaging demonstrates the less obvious features of genetic syndromes, providing a more understandable visualization of the fetal findings for parents and correlating well with the physical appearance of pathological specimens.
Although attempts at prevention of Treacher Collins syndrome using animal studies featuring chemical and genetic inhibition of the p53 protein have been made [4], currently no effective method of prevention in humans exists.
As the onset of abnormalities related to Treacher Collins syndrome occurs very early in the embryonic period (between the 4th and 8th weeks) [2], early ultrasonographic diagnosis is impossible at such an early gestational age.
In our opinion, a reasonable period for the ultrasonographic detection of de novo cases of Treacher Collins syndrome is the second trimester examination (usually performed between the 18th and 21st weeks), and, for family-history-positive cases, the period around 12 to 16 weeks of pregnancy.
Retrospectively, retrognathia was discernible in our case at 11 weeks, 4 days, but without a positive family history the diagnosis of Treacher Collins syndrome was not high on our index of suspicion. Second-trimester diagnosis offers the possibility of invasive testing and the option for termination of pregnancy.
In continuing pregnancies, postnatal management requires a multidisciplinary approach (obstetrician, neonatologist, surgeon, anesthesiologist, and geneticist); and due to possible acute breathing problems, delivery should be planned in specialized perinatal centers.
References1. Rotten D, Levaillant JM, Martinez H, Ducou le Pointe H, Vicaut E. The fetal mandible: a 2D and 3D sonographic approach to the diagnosis of retrognathia and micrognathia. Ultrasound Obstet Gynecol. 2002 Feb;19(2):122-30.
2. Trainor PA, Dixon J, Dixon MJ. Treacher Collins syndrome: etiology, pathogenesis and prevention. Eur J Hum Genet. 2009 Mar;17(3):275-83. Epub 2008 Dec 24.
3. Walker MB, Trainor PA. Craniofacial malformations: intrinsic vs extrinsic neural crest cell defects in Treacher Collins and 22q11 deletion syndromes. Clin Genet. 2006 Jun;69(6):471-9. Review.
4. Jones NC, Lynn ML, Gaudenz K, Sakai D, Aoto K, Rey JP, Glynn EF, Ellington L, Du C, Dixon J, Dixon MJ, Trainor PA. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.. Nat Med. 2008 Feb;14(2):125-33. Epub 2008 Feb 3.
5. Dudas M, Kaartinen V. Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face. Curr Top Dev Biol. 2005;66:65-133.
6. Kaartinen V, Dudas M, Nagy A, Sridurongrit S, Lu MM, Epstein JA. Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells. Development. 2004 Jul;131(14):3481-90.
7. Edwards SJ, Fowlie A, Cust MP, Liu DT, Young ID, Dixon MJ. Prenatal diagnosis in Treacher Collins syndrome using combined linkage analysis and ultrasound imaging. J Med Genet. 1996 Jul;33(7):603-6.
8. Dixon MJ. Treacher Collins syndrome. Hum Mol Genet. 1996;5 Spec No:1391-6. Review.
9. Jones KL: Treacher Collins syndrome. In Smith's recognizable patterns of human malformation. 6th edition. Philadelphia, Elsevier Saunders; 2006:280-281.
10. Li, C., Mernagh, J., Bourgeois, J. Novel craniofacial and extracraniofacial findings in a case of Treacher Collins syndrome with a pathogenic mutation and a missense variant in the TCOF1 gene. Clin. Dysmorph. 18: 63-68, 2009.
11. Jones KL: Retinoic acid embryopathy. In Smith's recognizable patterns of human malformation. 6th edition. Philadelphia, Elsevier Saunders; 2006:660-661.
12. Jones KL: Nager syndrome. In Smith's recognizable patterns of human malformation. 6th edition. Philadelphia, Elsevier Saunders; 2006:288-289.
13. Jones KL: Miller syndrome. In Smith's recognizable patterns of human malformation. 6th edition. Philadelphia, Elsevier Saunders; 2006:286-287.